Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)

https://www.grants.gov/web/grants/view-opportunity.html?oppId=341593
Award Amount
$2,500,000.00
Maximum Amount
$2,500,000.00
Assistance Type
Grant
Funding Source
Federal
Implementing Entity
National Institutes of Health
Due Date
Where the Opportunity is Offered
All of California
Eligible Applicant
Business
Additional Eligibility Information
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Contact
NIH OER Webmaster
Description

To ensure that digital therapeutics that have been or are in the development for SUD are adopted, this funding opportunity concept aims to fund clinical trials that will generate convincing data to improve adoption by the payors.

Category
Community Outreach and Capacity Building

Similar Oppportunities

HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional)
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed)
HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)
Last Updated